Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01492036 · ClinicalTrials.gov registry record
Long-Term Follow-Up of Recipient of Gene Transfer Research
A clinical trial of Cancer and Retroviridae Infections, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT01492036 is a study of Cancer and Retroviridae Infections that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 130 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01492036, a study of Cancer and Retroviridae Infections, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the long-term safety and any effects (good or bad) of gene transfer therapy.
Conditions Studied
Interventions
- OTHER Blood Tests
- BEHAVIORAL Questionnaires
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2011-12-09 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01492036
The ClinicalTrials.gov registry entry for NCT01492036 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Blood Tests is the first listed.
NCT01492036 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01492036 about?
NCT01492036 is a clinical study titled "Long-Term Follow-Up of Recipient of Gene Transfer Research". The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the lon...
What is the current status of trial NCT01492036?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2011-12-09. Estimated completion is 2027-12-31.
What conditions does trial NCT01492036 study?
This clinical trial studies the following conditions: Cancer, Retroviridae Infections.
What interventions are being tested in trial NCT01492036?
The interventions under investigation include: Blood Tests (OTHER), Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT01492036?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01492036 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
BfedBwell Optimization Pilot
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.